Can We Predict Thyroid Eye Disease Occurrence and Progression in Newly Diagnosed Graves’ Disease?
- 1 January 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Clinical Thyroidology
- Vol. 35 (1)
- https://doi.org/10.1089/ct.2023;35.9-11
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Predictive Model for Graves' Ophthalmopathy in Patients with New-Onset Graves' DiseaseThyroid®, 2022
- Statins Decrease the Risk of Orbitopathy in Newly Diagnosed Patients with Graves DiseaseJournal of Clinical Endocrinology & Metabolism, 2021
- Risk Factors of Thyroid Eye DiseaseEndocrine Practice, 2020
- Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ OrbitopathyFrontiers in Endocrinology, 2020
- Predictive score for the development or progression of Graves’ orbitopathy in patients with newly diagnosed Graves’ hyperthyroidismActa Endocrinologica, 2018
- High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional StudyThyroid®, 2018
- Graves' OphthalmopathyThe New England Journal of Medicine, 2010
- Thyroid-Associated Ophthalmopathy after Treatment for Graves’ Hyperthyroidism with Antithyroid Drugs or Iodine-131Journal of Clinical Endocrinology & Metabolism, 2009